IPO registrations (S-1, F-1) · Registrants

INTERMUNE INC

SEC CIK
1087432 · filings on EDGAR ↗
Name on the registration
INTERMUNE PHARMACEUTICALS INC
Former names
INTERMUNE PHARMACEUTICALS INC (2000–2001)
Registration
Form S-1, first filed 2000-02-02, last 2000-09-08; 2 initial registrations, 5 amendments
Outcome
Final prospectus filed 2000-03-27
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
3280 BAYSHORE, BLVD, Brisbane, CA 94005
EIN
94-3296648
EDGAR entity type
operating
Insiders and CEO pay
INTERMUNE INC on the corporate pages

Offering terms

Proposed price range
$17.00–$19.00 per share (S-1/A filed 2000-03-23)
Final price
$20.00 per share, above the range (424B1 filed 2000-03-27, an initial public offering)
Shares sold
6,250,000
Gross proceeds
$125,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ITMN
Lead underwriters
UBS (2,250,000 shares); Prudential Securities (1,250,000 shares); J.P. Morgan (1,500,000 shares)
Syndicate
Hambrecht & Quist; Description of Graphics; Bear Stearns (165,000); Oppenheimer (165,000); Robertson Stephens (165,000); Lehman Brothers (165,000); Cowen (165,000); Pacific Growth Equities, Inc (165,000); Adams Harkness (65,000); Legg Mason (65,000); Piper Sandler (65,000); Truist Securities (65,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 11

FiledFormWhat it isName as filedEDGAR
2000-02-02S-1S-1 (registration)INTERMUNE PHARMACEUTICALS INC0000912057-00-003537 ↗
2000-02-18S-1/AS-1/A (amendment)INTERMUNE PHARMACEUTICALS INC0000912057-00-007734 ↗
2000-03-06S-1/AS-1/A (amendment)INTERMUNE PHARMACEUTICALS INC0000912057-00-010052 ↗
2000-03-22S-1/AS-1/A (amendment)INTERMUNE PHARMACEUTICALS INC0000912057-00-012807 ↗
2000-03-23S-1/AS-1/A (amendment)INTERMUNE PHARMACEUTICALS INC0000912057-00-013053 ↗
2000-03-23S-1/AS-1/A (amendment)INTERMUNE PHARMACEUTICALS INC0000912057-00-013221 ↗
2000-03-24S-1MEFS-1MEF (added securities)INTERMUNE PHARMACEUTICALS INC0000912057-00-013282 ↗
2000-03-27424B1424B1 (final prospectus)INTERMUNE PHARMACEUTICALS INC0000912057-00-013630 ↗
2000-09-08S-1S-1 (registration)INTERMUNE PHARMACEUTICALS INC0000912057-00-040636 ↗
2001-06-29424B1424B1 (final prospectus)INTERMUNE INC0000912057-01-522148 ↗
2001-06-29424B1424B1 (final prospectus)INTERMUNE INC0000912057-01-522151 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2000-03-23S-1/Aregistration statement$17.00–$19.005,500,000-Nasdaq ITMN5from the submission text; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4document ↗
2000-03-27424B1final prospectus$20.006,250,000$125,000,000Nasdaq ITMN15from the submission text; price sentence, shares headline, proceeds table, underwriting table 13, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ARMSTRONG MARIANNEOfficerChief Med. Affairs/Reg. Off.; Chief Medical Affairs Officer; SVP Ch Reg & Drug Safety Off342006–2012
BLATT LAWRENCEOfficer; OtherChief Scientific Officer122006–2008
Bradford Williamson Z IIIOfficerSVP-Clinical Science; VP-Clinical Science; VP of Clinical Science352006–2012
Halleen NormanOfficer; OtherFormer SVP of Finance & CFO; SVP, Finance and CFO92006
Kassberg Thomas RichardOfficer; OtherSVP, Corp. Dev. & Comm. Oper.; SVP-Corp. Dev.& Comm. Oper.122006–2007
Porter Steven BryantOfficerChief Medical Officer362006–2012
Robinson Cynthia YOfficer; OtherSVP, Development Operations; SVP-Dev. Operations92006–2007
Simon Howard AllanOfficerSVP, Human Resources; SVP-Human Resources262006–2011
Steele Robin JoanOfficerSVP and General Counsel; SVP, GC, Secretary; SVP, General Counsel332006–2013
HAWLEY ROGEROther132006
HEALY JAMESDirector172006–2014
RINGO WILLIAM RDirector; Other42006–2008person page Fuzzy
WELCH DANIEL GDirector,OfficerCEO and President; Chairman, CEO and President; Charman, CEO and President452006–2014
KABAKOFF DAVID SDirector162006–2014
LEFF JONATHAN SDirector112006–2013
SMITH MICHAEL LDirector22006–2007
HODGMAN JOHNOfficerEVP, Finance & CFO; EVP-Finance & CFO; SVP, Finance & CFO; SVP-Finance & CFO332006–2014
Ekman LarsDirector122006–2014
HALTER WILLIAM AOther72006
HODGSON THOMAS ROther22006
DRAPEAU LOUISDirector122007–2014
Seiwert ScottOfficerSVP, Rsch, Preclinical & CMC; SVP, Rsearch/ Preclinical Dev.; SVP, Rsearch & Technical Dev.; VP, Research/Preclinical Dev.; VP, Rsearch/ Preclinical Dev.222009–2012
Di Nepi GiacomoOfficerEVP Managing Director, Europe; EVP, Managing Director, Europe; SVP, Managing Director, Europe152009–2014
Cohen Alan HowardOfficerSVP, Medical Affairs92009–2012
KAYE CHARLES RTenPercentOwner22010–2011
LANDY JOSEPHTenPercentOwner22010–2011
WARBURG PINCUS & CODirector,TenPercentOwner; TenPercentOwner22010–2011
WARBURG PINCUS EQUITY PARTNERS LPTenPercentOwner22010–2011
WARBURG PINCUS LLCTenPercentOwner22010–2011
Warburg Pincus Partners LLCDirector,TenPercentOwner; TenPercentOwner22010–2011
Russell Angus C.Director72011–2014
BIENAIME JEAN JACQUESDirector62012–2014
Verwiel FrankDirector62012–2014
Leff Jonathan AOfficerEVP of R&D; EVP, Research & Development142012–2014
ARATA PAUL DOfficerEVP, Human Resources & Admin; Executive VP of HR & Adm.; Senior VP of HR; Senior VP of HR & Adm.92012–2014
Nolan Sean P.OfficerEVP & CBO; Executive VP & CBO122013–2014
Powell Andrew Kenneth WilliamOfficerEVP, GC & Corp. Secretary; EVP, GC & Secretary72013–2014

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationInterMune, Inc.CAState business registriesname and state
Business registrationINTERMUNE, INC.CAState business registriesEIN (EXACT, as the state registration reports it)
Business registrationINTERMUNE, INC.CAState business registriesname and state
Federal award recipientINTERMUNE, INC.CAFederal spending (USAspending)name and state
Lobbying clientINTERMUNE, INC.CAFederal lobbying (LDA)name and state
Patent assigneeINTERMUNE, INC.CAPatents (USPTO)name and state
SEC filerINTERMUNE INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerIntermune, Inc.CATrademarks (USPTO)name and state
Form 5500 plan sponsorINTERMUNE INC.EIN (EXACT)
Person pageWilliam R RingoPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.